Oncology Institute (TOIIW) Other Non-Current Liabilities (2021 - 2026)

Oncology Institute (TOIIW) has reported Other Non-Current Liabilities for 6 consecutive years, with $19000.0 the latest figure, recorded in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $19000.0, down 83.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $19000.0 (down 83.76% YoY), and the FY2025 annual result was $28000.0, down 92.73% from the prior year.
• Other Non-Current Liabilities was $19000.0 for Q1 2026 at Oncology Institute, down from $28000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $13.7 million in Q3 2025 and troughed at $19000.0 in Q1 2026.
• Average Other Non-Current Liabilities over 5 years is $2.9 million, with a median of $514000.0 recorded in 2024.
• Year-over-year, Other Non-Current Liabilities plunged 96.37% in 2023 and surged 2557.2% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $4.0 million in 2022, then tumbled by 90.78% to $365000.0 in 2023, then rose by 5.48% to $385000.0 in 2024, then tumbled by 92.73% to $28000.0 in 2025, then tumbled by 32.14% to $19000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $19000.0 in Q1 2026, $28000.0 in Q4 2025, and $13.7 million in Q3 2025.